<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30808755</article-id>
<article-id pub-id-type="pmc">6397573</article-id>
<article-id pub-id-type="publisher-id">201818751</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1818751116</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Genetics</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The ubiquitin ligase UBE3B, disrupted in intellectual disability and absent speech, regulates metabolic pathways by targeting BCKDK</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Cheon</surname>
<given-names>Solmi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kaur</surname>
<given-names>Kiran</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nijem</surname>
<given-names>Nadine</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tuncay</surname>
<given-names>Islam Oguz</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kumar</surname>
<given-names>Pooja</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dean</surname>
<given-names>Milan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Juusola</surname>
<given-names>Jane</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guillen-Sacoto</surname>
<given-names>Maria J.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bedoukian</surname>
<given-names>Emma</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ierardi-Curto</surname>
<given-names>Lynne</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kaplan</surname>
<given-names>Paige</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schaefer</surname>
<given-names>G. Bradley</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>f</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mishra</surname>
<given-names>Prashant</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>g</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-3174-1480</contrib-id>
<name>
<surname>Chahrour</surname>
<given-names>Maria H.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
<xref ref-type="aff" rid="aff8">
<sup>h</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Eugene McDermott Center for Human Growth and Development, <institution>University of Texas Southwestern Medical Center</institution>, Dallas, <addr-line>TX</addr-line> 75390;</aff>
<aff id="aff2"><sup>b</sup>Department of Neuroscience, <institution>University of Texas Southwestern Medical Center</institution>, Dallas, <addr-line>TX</addr-line> 75390;</aff>
<aff id="aff3"><sup>c</sup><institution>GeneDx Inc.</institution>, Gaithersburg, <addr-line>MD</addr-line> 20877;</aff>
<aff id="aff4"><sup>d</sup>Roberts Individualized Medical Genetics Center, <institution>Children’s Hospital of Philadelphia</institution>, Philadelphia, <addr-line>PA</addr-line> 19104;</aff>
<aff id="aff5"><sup>e</sup>Division of Human Genetics and the Metabolic Disease Program, <institution>Children’s Hospital of Philadelphia</institution>, Philadelphia, <addr-line>PA</addr-line> 19104;</aff>
<aff id="aff6"><sup>f</sup>Division of Genetics, <institution>University of Arkansas for Medical Sciences</institution>, Little Rock, <addr-line>AR</addr-line> 72205;</aff>
<aff id="aff7"><sup>g</sup>Children’s Medical Center Research Institute, <institution>University of Texas Southwestern Medical Center</institution>, Dallas, <addr-line>TX</addr-line> 75390;</aff>
<aff id="aff8"><sup>h</sup>Department of Psychiatry, <institution>University of Texas Southwestern Medical Center</institution>, Dallas, <addr-line>TX</addr-line> 75390</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>1</sup>To whom correspondence should be addressed. Email: <email>maria.chahrour@utsouthwestern.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Edited by Arthur L. Beaudet, Baylor College of Medicine, Houston, TX, and approved January 4, 2019 (received for review October 31, 2018)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: P.M. and M.H.C. designed research; S.C., K.K., N.N., I.O.T., P. Kumar, M.D., J.J., M.J.G.-S., E.B., L.I.-C., P. Kaplan, G.B.S., P.M., and M.H.C. performed research; S.C., K.K., N.N., I.O.T., P. Kumar, M.D., P.M., and M.H.C. analyzed data; M.H.C. wrote the paper; J.J., M.J.G.-S., E.B., and G.B.S. referred subjects; and L.I.-C., P. Kaplan, and G.B.S. performed clinical phenotyping of subjects.</p>
</fn>
<fn fn-type="COI-statement">
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>26</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>11</day>
<month>2</month>
<year>2019</year>
</pub-date>
<volume>116</volume>
<issue>9</issue>
<fpage>3662</fpage>
<lpage>3667</lpage>
<permissions>
<copyright-year>2019</copyright-year>
<license>
<ali:license_ref specific-use="vor" xmlns:ali="http://www.niso.org/schemas/ali/1.0/"></ali:license_ref>
<license-p>Published under the <ext-link ext-link-type="uri" xlink:href="https://www.pnas.org/site/aboutpnas/licenses.xhtml">PNAS license</ext-link>.</license-p>
</license>
</permissions>
<self-uri xlink:href="pnas.201818751.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>UBE3B is a ubiquitin ligase disrupted in severe neurodevelopmental diseases (NDDs). Mechanistic studies on the function of UBE3B and its substrates have been lacking. Here, we show that deletion of <italic>Ube3b</italic> in mice causes neuroanatomical, behavioral, and metabolic abnormalities. Moreover, we identify BCKDK as a substrate UBE3B ubiquitinates. <italic>BCKDK</italic> is mutated in a spectrum of NDDs, and encodes a kinase that regulates several metabolic pathways. We show that <italic>UBE3B</italic> mutations are associated with metabolic disturbances in plasma from patients. Our findings place two NDD genes, <italic>UBE3B</italic> and <italic>BCKDK</italic>, in the same pathway, functionally validate the role of <italic>UBE3B</italic> in human disease, and identify both a disease mechanism in patients with <italic>UBE3B</italic> mutations and the downstream substrate that mediates this mechanism.</p>
</abstract>
<abstract>
<p>Kaufman oculocerebrofacial syndrome (KOS) is a recessive neurodevelopmental disorder characterized by intellectual disability and lack of speech. KOS is caused by inactivating mutations in <italic>UBE3B</italic>, but the underlying biological mechanisms are completely unknown. We found that loss of <italic>Ube3b</italic> in mice resulted in growth retardation, decreased grip strength, and loss of vocalization. The brains of <italic>Ube3b</italic><sup>−/−</sup> mice had hypoplasia of the corpus callosum, enlarged ventricles, and decreased thickness of the somatosensory cortex. <italic>Ube3b</italic><sup>−/−</sup> cortical neurons had abnormal dendritic morphology and synapses. We identified 22 UBE3B interactors and found that branched-chain α-ketoacid dehydrogenase kinase (BCKDK) is an in vivo UBE3B substrate. Since BCKDK targets several metabolic pathways, we profiled plasma and cortical metabolomes from <italic>Ube3b</italic><sup>−/−</sup> mice. Nucleotide metabolism and the tricarboxylic acid cycle were among the pathways perturbed. Substrate-induced mitochondrial respiration was reduced in skeletal muscle but not in liver of <italic>Ube3b</italic><sup>−/−</sup> mice. To assess the relevance of these findings to humans, we identified three KOS patients who had compound heterozygous <italic>UBE3B</italic> mutations. We discovered changes in metabolites from similar pathways in plasma from these patients. Collectively, our results implicate a disease mechanism in KOS, suggest that it is a metabolic encephalomyopathy, and provide an entry to targeted therapies.</p>
</abstract>
<kwd-group>
<kwd>intellectual disability</kwd>
<kwd>autism spectrum disorder</kwd>
<kwd>ubiquitination</kwd>
<kwd>BCKDK</kwd>
<kwd>UBE3B</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">Brain and Behavior Research Foundation (BBRF)<named-content content-type="funder-id">100000874</named-content></funding-source>
<award-id rid="sp1">Young Investigator grant</award-id>
<principal-award-recipient>Maria Chahrour</principal-award-recipient>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">HHS | NIH | National Institute of Mental Health (NIMH)<named-content content-type="funder-id">100000025</named-content></funding-source>
<award-id rid="sp2">R21 MH115313</award-id>
<principal-award-recipient>Maria Chahrour</principal-award-recipient>
</award-group>
</funding-group>
<counts>
<page-count count="6"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>